International Journal of Molecular Sciences,
Journal Year:
2017,
Volume and Issue:
18(10), P. 2168 - 2168
Published: Oct. 17, 2017
The
circadian
timing
system
(CTS)
controls
various
biological
functions
in
mammals
including
xenobiotic
metabolism
and
detoxification,
immune
functions,
cell
cycle
events,
apoptosis
angiogenesis.
Although
the
importance
of
CTS
is
well
known
pharmacology
drugs,
it
less
appreciated
at
clinical
level.
Genome-wide
studies
highlighted
that
majority
drug
target
genes
are
controlled
by
CTS.
This
suggests
chronotherapeutic
approaches
should
be
taken
for
many
drugs
to
enhance
their
effectiveness.
Currently
successfully
applied
treatment
different
types
cancers.
chronotherapy
approach
has
improved
tolerability
antitumor
efficacy
anticancer
both
experimental
animals
cancer
patients.
Thus,
chronobiological
have
been
determining
most
appropriate
time
administration
agents
minimize
side
effects
or
toxicity
efficacy,
so
as
optimize
therapeutic
ratio.
review
focuses
on
underlying
mechanisms
i.e.,
chronopharmacokinetics
chronopharmacodynamics
with
molecular
aspects,
provides
an
overview
some
recent
advances
development
chronopharmaceutics.
Cancer Research,
Journal Year:
2019,
Volume and Issue:
79(15), P. 3806 - 3814
Published: July 12, 2019
The
circadian
clock
is
a
master
regulator
of
mammalian
physiology,
regulating
daily
oscillations
crucial
biological
processes
and
behaviors.
Notably,
disruption
has
recently
been
identified
as
an
independent
risk
factor
for
cancer
classified
carcinogen.
As
such,
it
imperative
to
discern
the
underpinning
mechanisms
by
which
alters
risk.
Emergent
data,
reviewed
herein,
demonstrate
that
regulatory
functions
play
critical
roles
in
several
hallmarks
cancer,
including
control
cell
proliferation,
death,
DNA
repair,
metabolic
alteration.
Developing
deeper
understanding
circadian-cancer
regulation
cross-talk
holds
promise
developing
new
strategies
interception,
prevention,
management.
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: May 17, 2021
Dietary
restriction
(DR)
decreases
body
weight,
improves
health,
and
extends
lifespan.
DR
can
be
achieved
by
controlling
how
much
and/or
when
food
is
provided,
as
well
adjusting
nutritional
composition.
Because
these
factors
are
often
combined
during
DR,
it
unclear
which
necessary
for
beneficial
effects.
Several
drugs
have
been
utilized
that
target
nutrient-sensing
gene
pathways,
many
of
change
expression
throughout
the
day,
suggesting
timing
drug
administration
critical.
Here,
we
discuss
dietary
pharmacological
interventions
promote
a
healthy
lifespan
influencing
energy
intake
circadian
rhythms.
Cell,
Journal Year:
2018,
Volume and Issue:
174(4), P. 831 - 842.e12
Published: July 26, 2018
Overnutrition
disrupts
circadian
metabolic
rhythms
by
mechanisms
that
are
not
well
understood.
Here,
we
show
diet-induced
obesity
(DIO)
causes
massive
remodeling
of
enhancer
activity
in
mouse
liver,
triggering
synchronous
high-amplitude
both
fatty
acid
(FA)
synthesis
and
oxidation.
SREBP
expression
was
rhythmically
induced
DIO,
leading
to
FA
and,
surprisingly,
oxidation
(FAO).
DIO
similarly
caused
a
rhythm
PPARα,
which
also
required
for
FAO.
Provision
pharmacological
activator
PPARα
abrogated
the
requirement
FAO
(but
synthesis),
suggesting
indirectly
controls
via
production
endogenous
ligands.
The
imparted
time-of-day-dependent
responsiveness
lipid-lowering
drugs.
Thus,
acquisition
rhythmicity
non-core
clock
components
SREBP1
remodels
gene
transcription
response
overnutrition
enables
chronopharmacological
approach
disorders.
European Journal of Neuroscience,
Journal Year:
2018,
Volume and Issue:
51(1), P. 396 - 412
Published: Oct. 25, 2018
Abstract
Shift
work,
defined
as
work
occurring
outside
typical
daytime
working
hours,
is
associated
with
an
increased
risk
of
various
non‐communicable
diseases,
including
diabetes
and
cardiovascular
disease.
Disruption
the
internal
circadian
timing
system
concomitant
sleep
disturbances
thought
to
play
a
critical
role
in
development
these
health
problems.
Indeed,
controlled
laboratory
studies
have
shown
that
short‐term
misalignment
restriction
independently
impair
physiological
processes,
insulin
sensitivity,
energy
expenditure,
immune
function,
blood
pressure
cardiac
modulation
by
autonomous
nervous
system.
If
allowed
persist,
acute
effects
may
lead
cardiometabolic
diseases
long
term.
Here,
we
discuss
evidence
for
contributions
disruption
metabolic
problems
shift
workers.
Improving
understanding
mechanisms
affected
disturbance
will
contribute
implementation
strategies
prevent
or
mitigate
impact
work.
European Heart Journal,
Journal Year:
2022,
Volume and Issue:
43(19), P. 1799 - 1808
Published: Feb. 16, 2022
Decades
of
research
have
established
atherosclerosis
as
an
inflammatory
disease.
Only
recently
though,
clinical
trials
provided
proof-of-concept
evidence
for
the
efficacy
anti-inflammatory
strategies
with
respect
to
cardiovascular
events,
thus
offering
a
new
paradigm
lowering
residual
vascular
risk.
Efforts
target
inflammasome-interleukin-1β-interleukin-6
pathway
been
highly
successful,
but
inter-individual
variations
in
drug
response,
lack
reduction
all-cause
mortality,
and
higher
rate
infections
also
highlight
need
second
generation
agents
targeting
atherosclerosis-specific
immune
mechanisms
while
minimizing
systemic
side
effects.
CC-motif
chemokine
ligand
2/monocyte-chemoattractant
protein-1
(CCL2/MCP-1)
orchestrates
monocyte
trafficking
between
bone
marrow,
circulation,
atherosclerotic
plaques
by
binding
its
cognate
receptor
CCR2.
Adding
strong
body
data
from
experimental
models,
coherent
series
recent
large-scale
genetic
observational
epidemiological
studies
along
human
relevance
therapeutic
potential
CCL2-CCR2
axis
atherosclerosis.
Here,
we
summarize
pinpointing
emerging
Furthermore,
contextualize
previous
efforts
interfere
this
pathway,
scrutinize
approaches
vs.
targeting,
discuss
possible
pathway-intrinsic
opportunities
challenges
related
pharmacological
Science,
Journal Year:
2023,
Volume and Issue:
379(6631), P. 478 - 483
Published: Feb. 2, 2023
The
circadian
clock
modulates
human
physiology.
However,
the
organization
of
tissue-specific
gene
expression
rhythms
and
how
these
depend
on
age
sex
is
not
defined
in
humans.
We
combined
data
from
Genotype-Tissue
Expression
(GTEx)
project
with
an
algorithm
that
assigns
phases
to
914
donors,
by
integrating
temporal
information
multiple
tissues
each
individual,
identify
messenger
RNA
(mRNA)
46
tissues.
Clock
transcripts
showed
conserved
timing
relationships
tight
synchrony
across
body.
mRNA
varied
breadth,
covering
global
functions,
including
metabolic
pathways
systemic
responses.
structure
was
sexes
groups.
overall
were
highly
sex-dimorphic
more
sustained
females.
Rhythmic
programs
generally
dampened
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(2)
Published: Jan. 3, 2023
Hepatocellular
carcinoma
(HCC)
remains
a
global
health
challenge
whose
incidence
is
growing
worldwide.
Previous
evidence
strongly
supported
the
notion
that
circadian
clock
controls
physiological
homeostasis
of
liver
and
plays
key
role
in
hepatocarcinogenesis.
Despite
progress,
cellular
molecular
mechanisms
underpinning
this
HCC-clock
crosstalk
remain
unknown.
Addressing
knowledge
gap,
we
show
here
although
human
HCC
cells
Hep3B,
HepG2,
Huh7
displayed
variations
rhythm
profiles,
all
relied
on
master
transcription
factors,
BMAL1
CLOCK,
for
sustained
cell
growth.
Down-regulating
Bmal1
or
Clock
induced
apoptosis
arrested
cycle
at
G
2
/M
phase.
Mechanistically,
found
inhibiting
/
dysregulation
regulators
Wee1
p21
which
cooperatively
contribute
to
tumor
death.
knockdown
caused
downregulation
led
activation
upregulation
Collectively,
our
results
suggest
CLOCK
promote
proliferation
by
controlling
levels,
thereby
preventing
arrest.
Our
findings
shed
light
impact
proteins
maintaining
oncogenesis
provide
proof-of-principle
developing
cancer
therapy
based
modulation
clock.
PLoS Biology,
Journal Year:
2022,
Volume and Issue:
20(3), P. e3001567 - e3001567
Published: March 24, 2022
The
circadian
clock
is
an
evolutionarily
highly
conserved
endogenous
timing
program
that
structures
physiology
and
behavior
according
to
the
time
of
day.
Disruption
rhythms
associated
with
many
common
pathologies.
emerging
field
medicine
aims
exploit
mechanisms
clock–disease
interaction
for
clinical
diagnosis,
treatment,
prevention.
In
this
Essay,
we
outline
principle
approaches
medicine,
highlight
development
in
selected
areas,
point
out
open
questions
challenges.
Circadian
has
unambiguous
health
benefits
over
standard
care
but
rarely
utilized.
It
biology
become
integrated
part
translational
research.
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(7)
Published: Feb. 6, 2024
Studies
in
shift
workers
and
model
organisms
link
circadian
disruption
to
breast
cancer.
However,
molecular
rhythms
noncancerous
cancerous
human
tissues
their
clinical
relevance
are
largely
unknown.
We
reconstructed
informatically,
integrating
locally
collected,
time-stamped
biopsies
with
public
datasets.
For
tissue,
inflammatory,
epithelial–mesenchymal
transition
(EMT),
estrogen
responsiveness
pathways
show
modulation.
Among
tumors,
clock
correlation
analysis
demonstrates
subtype-specific
changes
organization.
Luminal
A
organoids
informatic
ordering
of
luminal
samples
exhibit
continued,
albeit
dampened
reprogrammed
rhythms.
CYCLOPS
magnitude,
a
measure
global
rhythm
strength,
varied
widely
among
samples.
Cycling
EMT
pathway
genes
was
markedly
increased
high-magnitude
tumors.
Surprisingly,
patients
tumors
had
reduced
5-y
survival.
Correspondingly,
3D
cultures
invasion
following
disruption.
This
study
links
cancer
EMT,
metastatic
potential,
prognosis.
Proceedings of the National Academy of Sciences,
Journal Year:
2018,
Volume and Issue:
115(39)
Published: Sept. 10, 2018
Circadian
clocks
play
a
key
role
in
regulating
vast
array
of
biological
processes,
with
significant
implications
for
human
health.
Accurate
assessment
physiological
time
using
transcriptional
biomarkers
found
blood
can
significantly
improve
diagnosis
circadian
disorders
and
optimize
the
delivery
therapeutic
treatments.
To
be
useful,
such
test
must
accurate,
minimally
burdensome
to
patient,
readily
generalizable
new
data.
A
major
obstacle
development
gene
expression
biomarker
tests
is
diversity
measurement
platforms
inherent
variability
data,
often
resulting
predictors
that
perform
well
original
datasets
but
cannot
universally
applied
samples
collected
other
settings.
Here,
we
introduce
TimeSignature,
an
algorithm
robustly
infers
from
expression.
We
demonstrate
its
application
data
three
independent
studies
distinct
microarrays
further
validate
it
against
set
profiled
by
RNA-sequencing.
Our
results
show
TimeSignature
more
accurate
efficient
than
competing
methods,
estimating
within
2
h
majority
samples.
Importantly,
once
trained
on
single
study,
predictor
yield
highly
differences
study
population,
patient
protocol,
or
assay
platform
without
renormalizing
retraining.
This
feature
unique
among
expression-based
addresses
challenge
generalizable,
clinically
useful
tests.